This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
We know by now that while most cases of the Coronavirus are mild and highly manageable (as many as 82% by March 8), the new virus is most dangerous for the elderly and those with compromised immunity. This is why it’s perfectly understandable that even as sensible opinion leaders caution us to be alert but not anxious, Myasthenia gravis patients have more reason to worry than most. .
The Coronavirus Disease 2019 (COVID-19) is wreaking havoc around the globe. With a seemingly imminent pandemic on the horizon, healthcare organizations are rushing to prepare for the fallout. The Centers for Disease Control and Prevention warned that it expects the novel coronavirus that has sparked outbreaks around the world to begin spreading at a community level in the United States.
Chances are, there’s not a day that goes by where you don’t hear the words coronavirus. The virus has gripped the world, leaving many glued to their television sets, phones, or other communication devices. With substantial evidence contributing to the fear, the false information floating around further compounds the issue. Through reliable sources, we have.
How COVID 19 Is Affecting Clinical Research Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Send in
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
While the economic impact is unknown scenario planning is key. The impact and effects of COVID-19 are being felt by businesses globally, and particularly in China where necessary radical measures to contain the outbreak are impacting day to day life. Accurately predicting the eventual impact of the outbreak is challenging at this stage – the China economy has become much more integrated with the global economy since the 2002-2003 SARS crisis and grown 7 times in size The outbreak presents specif
Conferences can be indicative of the mood in an industry. They set the stage for what is to come, and also the issues and challenges being faced at that very moment. SCOPE Summit 2020 in Orlando was no exception to that rule. There was a noticeable country absence at the event, which was a great shame, as there are currently some fantastic initiatives and trials being operated and brought out of the Far East and China.
Conferences can be indicative of the mood in an industry. They set the stage for what is to come, and also the issues and challenges being faced at that very moment. SCOPE Summit 2020 in Orlando was no exception to that rule. There was a noticeable country absence at the event, which was a great shame, as there are currently some fantastic initiatives and trials being operated and brought out of the Far East and China.
How COVID 19 Is Affecting Clinical Research. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education.
Below is a copy of Gabriel Levitt’s comments on the FDA Notice of Proposed Rulemaking titled “Importation of Prescription Drugs” that were submitted Monday, March 9th, 2020. Comments on Notice of Proposed Rulemaking titled “Importation of Prescription Drugs, FDA-2019-N-5711, 84 Fed. Reg. 70796 “ Docket No. FDA-2019-N-5711.
Medicines Discovery Catapult (MDC) have welcomed a cohort of MRC-funded PhD students as part of a training, talent and skills agenda to help develop the next generation of drug discovery researchers.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content